D. E. Shaw & Co. Inc. purchased a new stake in shares of Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report) during the 4th quarter, Holdings Channel reports. The fund purchased 350,000 shares of the company’s stock, valued at approximately $6,454,000.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Parallax Volatility Advisers L.P. purchased a new position in Translational Development Acquisition during the 4th quarter valued at about $929,000. Wealthspring Capital LLC purchased a new position in Translational Development Acquisition during the 4th quarter valued at about $1,095,000. Yakira Capital Management Inc. purchased a new position in Translational Development Acquisition during the 4th quarter valued at about $1,106,000. Warberg Asset Management LLC purchased a new position in Translational Development Acquisition during the 4th quarter valued at about $1,373,000. Finally, Centiva Capital LP purchased a new position in Translational Development Acquisition during the 4th quarter valued at about $1,844,000.
Translational Development Acquisition Trading Down 0.2%
NASDAQ TDACU opened at $10.25 on Friday. The firm’s 50-day simple moving average is $10.19. Translational Development Acquisition Corp. has a one year low of $10.00 and a one year high of $10.30.
About Translational Development Acquisition
Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.
Read More
- Five stocks we like better than Translational Development Acquisition
- Airline Stocks – Top Airline Stocks to Buy Now
- Walmart Stock Alert: Big Price Move Expected Soon
- NYSE Stocks Give Investors a Variety of Quality Options
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report).
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.